CID is 5280723
synonyms found at PubChem are:
Prostaglandin E1, alprostadil, 745-65-3, PGE1, Edex, Muse, Caverject, Prostin VR, Alprostadilum, Prostavasin, Topiglan, Vasaprostan, Femprox, Befar, Alprox-TD, Liprostin, Prostandin, Sugiran, Viridal, Vitaros, PGE1 Oligomer, PGE-1, Befar (TN), Prink (TN), Alista, Prink, FemLife, RayVa, l-Prostaglandin E1, MR-256, Minprog, UNII-F5TD010360, Alprostadil(Caverject), MR 256, CHEMBL495, Prostin VR Pediatric, Prostin VR pediatric (TN), (11alpha,13E,15S)-11,15-dihydroxy-9-oxoprost-13-en-1-oic acid, Alprostadil Prostoglandin E1, Lipoprost, Prostivas, 11alpha,15alpha-Dihydroxy-9-oxo-13-trans-prostenoic acid, BML1-F06, (13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate, CHEBI:15544, PGE1alpha, HEI-507, 9-oxo-11R,15S-dihydroxy-13E-prostaenoic acid, GMVPRGQOIOIIMI-DWKJAMRDSA-N, U-10136, 7-[(1R,2R,3R)-3-hydroxy-2-[(E,3S)-3-hydroxyoct-1-enyl]-5-oxocyclopentyl]heptanoic acid, F5TD010360, (-)-Protaglandin E1, (13E,15S)-11alpha,15-dihydroxy-9-oxoprost-13-en-1-oic acid, l-PGE1, Alprostadilum [INN-Latin], 7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-en-1-yl)-5-oxocyclopentyl)heptanoic acid, Promostan, (11alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-enoic acid, ONO 1608, EINECS 212-017-2, Prostaglandine E, Caverject Impulse, NSC 165559, Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11alpha,13E,15S)-, homopolymer, CPD000112594, SMR000112594, AI3-62116, U 10136, SR-01000597593, Lipo-alprostadil, 3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid, l-3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid, Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11alpha,13E,15S)-, Prostaglandin-E1, Alprostadil(usan), (1R,2R,3R)-3-Hydroxy-2-((E)-(3S)-3-hydroxy-1-octenyl)-5-oxocyclopentaneheptanoic acid, Caverject (TN), NCGC00016535-01, 119314-69-1, CAS-745-65-3, Vitaros (TN), (13E)-(15S)-11-alpha,15-dihydroxy-9-oxoprost-13-enoate, Alprostadil [USAN:USP:INN:BAN:JAN], Edex (TN), Muse (TN), AC1NQXHQ, 11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid, PGE1;Prostaglandin E1, Prestwick2_001018, Prestwick3_001018, U-10,136, DSSTox_CID_2578, D0I4DQ, D0N2EF, DSSTox_RID_76640, DSSTox_GSID_22578, SCHEMBL33317, BSPBio_001175, BSPBio_001488, MLS000758964, MLS001424250, BIDD:GT0747, BPBio1_001293, GTPL1882, Alprostadil (JP15/USP/INN), Alprostadil (JP17/USP/INN), Cyclopentaneheptanoic acid, 3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-, l-, DTXSID9022578, SYN3025, MolPort-003-939-183, HMS1361K10, HMS1571K17, HMS1791K10, HMS1989K10, HMS2052L11, HMS2090L08, HMS2098K17, HMS3268I09, HMS3402K10, HMS3648O17, HMS3715K17, BCP01740, EX-A1411, HY-B0131, ZINC3813088, Tox21_110482, BDBM50101853, BG0025, LMFA03010134, MFCD00077860, s1508, AKOS015961103, Prost-13-en-1-oic acid, 11,15-dihydroxy-9-oxo-, (11.alpha.,13E,15S)-, AC-6095, BCP9000277, CCG-101188, CS-1905, NC00438, RP17688, IDI1_033958, Prostaglandin E1, >=99.0% (TLC), SMP2_000271, NCGC00025234-02, NCGC00025234-03, NCGC00025234-04, NCGC00025234-05, AS-16360, BC205461, K274, SAM001246840, SAM001246845, SAM001247093, AB0014134, AB2000131, 11,15-Dihydroxy-9-oxoprost-13-en-1-oate, AB00514004, B2154, ST50826271, Alprostadil, meets USP testing specifications, C04741, D00180, Prostaglandin E1, >=98% (HPLC), synthetic, Prostaglandin E1;Edex;Muse;Liprostin;Caverject, AB00514004-06, AB00514004-08, AB00514004_09, 745P653, SR-01000946253, SR-01000597593-1, SR-01000597593-5, SR-01000597593-6, SR-01000946253-1, W-104416, BRD-K52459643-001-06-0, BRD-K52459643-001-10-2, BRD-K52459643-001-17-7, (13E)-(15S)-11,15-dihydroxy-9-oxoprost-13-enoate, (13E)-(15S)-11,15-dihydroxy-9-oxoprost-13-enoic acid, Alprostadil, European Pharmacopoeia (EP) Reference Standard, (13e)-(15s)-11alpha,15-dihydroxy-9-oxoprost-13-enoic acid, (11?,13E,15S)-11,15-Dihydroxy-9-oxo-prost-13-en-1-oic acid, (13E)-(15S)-11-alpha,15-dihydroxy-9-oxoprost-13-enoic acid, 11,15-dihydroxy-9-oxoprost-13-en-1-oic acid (ACD/Name 4.0), 3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoate, 3-Hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-cyclopentaneheptanoic acid, Alprostadil, United States Pharmacopeia (USP) Reference Standard, (+)-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-Cyclopentaneheptanoate, (+)-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-Cyclopentaneheptanoic acid, (-)-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-Cyclopentaneheptanoate, (-)-3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-Cyclopentaneheptanoic acid, Prostaglandin E1, synthetic, powder, BioReagent, suitable for cell culture, 7-((1R,2R,3R)-3-hydroxy-2-((S,E)-3-hydroxyoct-1-enyl)-5-oxocyclopentyl)heptanoic acid, 7-[(1r,3r)-3-Hydroxy-2-[(1e,3s)-3-Hydroxyoct-1-En-1-Yl]-5-Oxocyclopentyl]heptanoic Acid, Cyclopentaneheptanoic acid, 3-hydroxy-2-(3-hydroxy-1-octenyl)-5-oxo-, (-)-, Prostaglandin E1, powder, gamma-irradiated, BioXtra, suitable for cell culture, 22299-37-2, 50-83-9, 50865-30-0, 7-[5-((1E)(3S)-3-hydroxyoct-1-enyl)(1R,4R,5R)-4-hydroxy-2-oxocyclopentyl]hepta noic acid, XPG